Ironwood Pharmaceuticals (IRWD) Other Working Capital Changes (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) reported Other Working Capital Changes of -$621000.0 for Q1 2026, down 8.57% on a YoY basis from -$679181.6 in Q1 2025, and down 1.47% sequentially from -$612000.0 in Q4 2025.
Ironwood Pharmaceuticals (IRWD) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals (IRWD) has 9 years of Other Working Capital Changes data on file, last reported at -$621000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 8.57% year-over-year to -$621000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.4 million (down 8.76% YoY), and the FY2025 full-year result was -$2.4 million, down 8.96% from the prior year.
- Other Working Capital Changes eased to -$621000.0 in Q1 2026, from -$612000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.6 million in Q1 2024 to a low of -$6.1 million in Q4 2023.
- A 5-year average of -$295882.4 and a median of -$75000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes declined 9.77% in 2022 and increased 0.83% in 2023, its largest moves.
- Tracing IRWD's Other Working Capital Changes over 5 years: stood at -$473000.0 in 2022, then retreated by 9.09% to -$516000.0 in 2023, then decreased by 8.91% to -$562000.0 in 2024, then retreated by 8.9% to -$612000.0 in 2025, then dropped by 1.47% to -$621000.0 in 2026.
- Business Quant data shows IRWD's Other Working Capital Changes at -$621000.0 in Q1 2026, -$612000.0 in Q4 2025, and -$603000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ironwood Pharmaceuticals | 619.48 Mn | 399.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121,000.00 |
| Mar 31, 2026 | -121,000.00 |
| Mar 31, 2026 | -121,000.00 |
| Dec 31, 2025 | -1.17 Mn |
| Dec 31, 2025 | -1.17 Mn |
| Dec 31, 2025 | -1.17 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | -143,000.00 |
| Jun 30, 2025 | -143,000.00 |
| Jun 30, 2025 | -143,000.00 |
| Mar 31, 2025 | -141,000.00 |
| Mar 31, 2025 | -141,000.00 |
| Mar 31, 2025 | -141,000.00 |
| Dec 31, 2024 | -2.27 Mn |
| Dec 31, 2024 | -2.27 Mn |
| Dec 31, 2024 | -2.27 Mn |
| Sep 30, 2024 | -357,000.00 |
| Sep 30, 2024 | -357,000.00 |